Biomedical subjects
Publications and source records attributed to Warren J Manning.
These "Guidelines for Training in Cardiovascular Magnetic Resonance" were developed by the Clinical Practice Committee of the Society for Cardiovascular Magnetic Resonance (SCMR) and approved by the SCMR Board of Trustees.
BACKGROUND: Patients with type 1 diabetes and nephropathy maintain an excess cardiovascular mortality compared with diabetic patients with normoalbuminuria. We sought to evaluate coronary and aortic atherosclerosis in a cohort of asymptomatic type 1 diabetic patients with and without diabetic nephropathy using cardiovascular magnetic resonance imaging. METHODS AND RESULTS: In a cross-sectional study, 136 subjects with long-standing type 1 diabetes without symptoms or history of cardiovascular disease, including 63 patients (46%) with nephropathy and 73 patients with normoalbuminuria, underwent cardiovascular magnetic resonance imaging. All subjects underwent cardiac exercise testing and noninvasive tests for peripheral artery disease and autonomic neuropathy. Coronary artery stenoses were identified in 10% of subjects with nephropathy (versus 0% with normoalbuminuria; P=0.007). Coronary plaque burden, expressed as right coronary artery mean wall thickness (1.7+/-0.3 versus 1.3+/-0.2 mm; P<0.001) and maximum right coronary artery wall thickness (2.2+/-0.5 versus 1.6+/-0.3 mm; P<0.001), was greater in subjects with nephropathy. The prevalence of thoracic (3% versus 0%; P=0.28) and abdominal aortic plaque (22% versus 16%; P=0.7) was similar in both groups. Subjects with and without abdominal aortic plaques had similar coronary plaque burden. CONCLUSIONS: In asymptomatic type 1 diabetes, cardiovascular magnetic resonance imaging reveals greater coronary plaque burden in subjects with nephropathy compared with those with normoalbuminuria.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
BACKGROUND: End stage (ES) is a recognized part of the hypertrophic cardiomyopathy (HCM) disease spectrum. Frequency, clinical profile and course, and treatment strategies in these patients remain incompletely defined. METHODS AND RESULTS: Three HCM cohorts comprised 1259 patients, including 44 (3.5%) characterized as ES with systolic dysfunction (ejection fraction <50% at rest; range 15% to 49%). ES developed at a wide age range (14 to 74 years), with 45% of patients < or = 40 years old. Although 29 patients (66%) died of progressive heart failure, had sudden death events, or underwent heart transplantation, 15 (34%) survived with medical management over 3+/-3 years. Duration from onset of HCM symptoms to ES identification was considerable (14+/-10 years), but ES onset to death/transplantation was brief (2.7+/-2 years). ES occurred with similar frequency in patients with or without prior myectomy (P=0.84). Appropriate defibrillator interventions were 10% per year in patients awaiting donor hearts. Most ES patients (n=23; 52%) showed substantial left ventricular (LV) remodeling with cavity dilatation. Less complete remodeling occurred in 21 patients (48%), including 5 with persistence of a nondilated and markedly hypertrophied LV. Pathology and magnetic resonance imaging showed extensive (transmural) fibrosis in 9 of 11 ES patients. At initial evaluation, patients who developed ES were younger with more severe symptoms, had a larger LV cavity, and more frequently had a family history of ES than other HCM patients. CONCLUSIONS: ES of nonobstructive HCM has an expanded and more diverse clinical expression than previously appreciated, including occurrence in young patients, heterogeneous patterns of remodeling, frequent association with atrial fibrillation, and impaired LV contractility that precedes cavity dilatation, wall thinning, and heart failure symptoms. ES is an unfavorable complication (mortality rate 11% per year) and a sudden death risk factor; it requires vigilance to permit timely recognition and the necessity for defibrillator implantation and heart transplantation.
AIMS: We sought to evaluate the utility of contrast-enhanced coronary magnetic resonance imaging (CE-MRI) for selective visualization and non-invasive differentiation of atherosclerotic coronary plaque in humans. METHODS AND RESULTS: Nine patients with coronary artery disease (CAD) as confirmed by X-ray angiography and multidetector computed tomography (MDCT) were studied by T1-weighted black blood inversion recovery coronary MRI before (N-IR) and after administration of Gd-DTPA (CE-IR). Plaques were categorized as calcified, non-calcified, and mixed based on their Hounsfield number derived from MDCT. With MDCT, a total of 29 plaques were identified, including calcified (n=6), non-calcified (n=6), and mixed calcified/non-calcified (n=17). On N-IR MRI, 26 plaques (90%) were dark, whereas three plaques (two non-calcified and one mixed) appeared bright. On CE-MRI, 13/29 (45%) plaques, 11 of which were mixed, one non-calcified, and one calcified showed contrast uptake. All others remained dark. CONCLUSION: In this preliminary study, we demonstrate the potential utility of CE-IR MRI for selective plaque visualization and differentiation of plaque types. The observed contrast uptake may be associated with endothelial dysfunction, neovascularization, inflammation, and/or fibrosis.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
This study sought to establish the practice patterns of a diverse group of academic physicians, in the management of periprocedural anticoagulation for patients with mechanical heart valves, to study adherence to American College of Cardiology/American Heart Association (ACC/AHA) guidelines. Physicians (n = 140) were surveyed to assess strategies for the periprocedural anticoagulation of patients with bileaflet mechanical heart valves undergoing 2 common outpatient procedures. Six patient scenarios with graded risk profiles were presented for each valve location (mitral and aortic). In >90% of high-risk patient scenarios, for which the ACC/AHA guidelines recommend periprocedural anticoagulation, anticoagulation was recommended, with minimal differences between physician specialties. However, periprocedural anticoagulation was also recommended in >70% of non-high-risk scenarios, for which the ACC/AHA guidelines recommend no periprocedural anticoagulation. Noncardiologists recommended anticoagulation more often in non-high-risk patients (p <0.01), especially for patients with aortic valve prostheses. Thus, academic physicians appropriately recommend periprocedural anticoagulation for high-risk patients with mechanical heart valves who undergo elective procedures. However, these data specifically suggest variability in practice for non-high-risk patients that are discordant with current ACC/AHA guidelines, with differences by treating specialty especially notable in this risk subset.
Explore the source record for details and available documents.
PURPOSE: To compare radial and spiral k-space sampling in navigator-gated ECG-triggered three-dimensional (3D) coronary vessel wall imaging. MATERIALS AND METHODS: The right coronary artery (RCA) vessel walls of eight healthy subjects were imaged using a modified double-inversion prepulse in concert with radial and spiral data acquisition. For data analysis, two investigators blinded to the sequence parameters subjectively assessed image quality in terms of artifacts and vessel wall visualization. Objective measures of the signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and vessel wall definition were also determined. RESULTS: Radial k-space sampling demonstrated fewer artifacts and led to improved visualization of the coronary vessel wall compared to spiral imaging (P < 0.05). This finding was also reflected in a better vessel wall definition using radial data acquisition (P < 0.05). SNR and CNR were found to be higher when spiral k-space sampling was used (n.s.). CONCLUSION: Radial k-space sampling in concert with free-breathing navigator-gated cardiac-triggered MRI of the coronary vessel wall resulted in fewer motion artifacts and improved vessel wall definition compared to spiral k-space sampling. The proposed approach therefore appears to be preferable.
The undersampled radial acquisition has been widely employed for accelerated (by a factor R = N(r)/N(p)) cardiac imaging, but the resulting reduction in image quality has not been well characterized. This investigation presents a method of measuring these artifacts through synthetic undersampling of high SNR images (SNR > or = 30). After validating the method in phantoms, the method was applied to a study of short-axis, long-axis, and coronary MRI imaging in healthy subjects. For 60 projections (60 N(p)), the total artifact is approximately 10% for short and long-axis imaging (R = 2.1) and approximately 15% for coronary MRI (R = 3.7). For 60 N(p), the SD of artifact in the region of the heart is 2% for short- and long-axis imaging (R = 2.1) and 3.5% for coronary MRI (R = 3.7). The artifact content is less in the region of the heart than in the periphery. The artifact is very reproducible among subjects for standard views. A study of coronary MRI at progressively fewer projections (at constant scan time) showed that right coronary MRI images were acceptable if total artifact was <6.5% of image content (N(p) > 120, R = 2.1).
The radial trajectory has found applications in cardiac imaging because of its resilience to undersampling and motion artifacts. Recent work has shown that interleaved and weighted radial imaging can produce images with multiple contrasts from a single data set. This feature was investigated for inversion recovery imaging of scar using a radial technique. The 2D radial imaging method was modified to acquire quadruply interleaved projection sets within each acquisition window of the cardiac cycle. These data were reconstructed using k-space weightings that used a smaller segment of the acquisition window for the central k-space data, the determinant of image contrast. This method generates four images with different T1 weightings. The novel approach was compared with noninterleaved radial imaging, interleaved radial without weightings, and Cartesian imaging in simulations, phantoms, and seven subjects with clinical myocardial infarction. The results show that during a typical acquisition window after an inversion pulse, magnetization changes rapidly. The interleaved acquisition provided better image quality than the noninterleaved radial acquisition. Interleaving with weighting provided better quality when the inversion time (TI) was shorter than optimal; otherwise, interleaving without weighting was superior. These methods enable a radial trajectory to be employed in conjunction with preparation pulses for viability imaging.
BACKGROUND: Understanding pulmonary vein (PV) anatomy is important for the planning and execution of PV isolation for the treatment of atrial fibrillation, screening for PV stenosis after the procedure, and investigating the pathophysiology of atrial fibrillation. We hypothesized that significant changes in PV size occur during the cardiac cycle and sought to identify the relationship of data obtained with conventional non-electrocardiogram (ECG)-gated methods compared with ECG-gated measures of PV size using cardiovascular magnetic resonance. METHODS: A consecutive series of 14 patients in sinus rhythm were evaluated with non-ECG-gated contrast-enhanced magnetic resonance angiography and ECG-gated cine cardiovascular magnetic resonance of the PV. Pulmonary vein diameter, perimeter, and cross-sectional area (CSA) were measured using both methods. RESULTS: Maximum diameter, perimeter, and CSA occurred simultaneously in all PV. The timing of the maximum size varied but generally occurred in ventricular diastole (101 +/- 112 milliseconds after mitral valve opening). The timing of minimum PV size also varied but generally occurred in ventricular systole (212 +/- 90 milliseconds before mitral valve opening). The difference between the maximum and minimum PV size was 15% +/- 8% for diameter, 15% +/- 7% for perimeter, and 27% +/- 12% for CSA (P < .001 for all). Contrast-enhanced magnetic resonance angiography correlated best with the ECG-gated maximum PV size (R2 > 0.48, P < .001 for all) and was greater than the minimum and average PV sizes (P < .05 for all). CONCLUSIONS: All measures of PV size vary significantly during the cardiac cycle. Contrast-enhanced magnetic resonance angiography PV measurements correlate best with maximum PV size.
OBJECTIVES: We sought to define right atrial appendage (RAA) anatomic and functional parameters in a consecutive series of participants and to compare these measures with left atrial appendage (LAA) indices among patients with in sinus rhythm and atrial fibrillation (AF). BACKGROUND: With AF, both atria are fibrillating, yet the vast majority of thrombi are located within the LAA. Transesophageal echocardiography provides anatomic and functional information regarding both the LAA and the RAA. METHODS: In a consecutive series of 92 patients (48 men; age 61 +/- 17 years) referred for transesophageal echocardiography, RAA and LAA anatomy (width, length, area) and ejection velocity were measured at two orientations (RAA, 90 and 135 degrees; LAA, 0 and 90 degrees). RESULTS: RAA anatomic measures were similar for both imaging planes, whereas LAA area was larger at 90 degrees. There was a modest correlation between RAA and LAA anatomic measures (area: r = 0.58, P = .001). RAA neck width was substantially greater than LAA neck width (P < .0001) whereas appendage area was similar (P = not significant) and RAA neck width/area was greater than LAA neck width/area (P < .0001). AF was associated with approximately 50% decline in ejection velocity for both the LAA and the RAA with an increase in LAA area (P = .006 vs sinus), but similar anatomic remodeling was not found for the RAA (P = not significant vs sinus). CONCLUSION: In this consecutive series of patients undergoing transesophageal echocardiography, RAA anatomic and functional parameters were found to be independent of imaging plane, with anatomic measures demonstrating a correlation with LAA measures. Although AF is associated with depressed RAA and LAA ejection velocities, anatomic RAA remodeling appears to be absent. The larger RAA width and lack of anatomic remodeling may partially explain the substantially lower prevalence of RAA thrombus found among patients with AF.
BACKGROUND: Cardiovascular magnetic resonance (CMR) is widely recognized as a non-invasive gold standard for quantification of ventricular volumes. In addition, it is an emerging diagnostic modality for clinical evaluation of mitral regurgitation (MR) and aortic regurgitation (AR). CMR facilitates accurate quantitation of regurgitation volumes and regurgitant fraction, but referring physicians are often more comfortable with qualitative measures, and few data exist for correlation of qualitative CMR regurgitation severity with that obtained by more conventional qualitative Doppler echocardiography. Because patients with AR and MR may commonly be assessed by both echocardiography and CMR modalities, consistency between qualitative gradient of regurgitation severity is important for follow-up. Therefore, we sought to define the CMR regurgitant fractions that best correlate with qualitative mild, moderate, and severe regurgitation by color Doppler echocardiography. METHODS AND RESULTS: Data from 141 consecutive patients (age 53 +/- 15 yr; 43% female) with contemporary (median, 31 days) CMR and echocardiographic data, including 107 regurgitant valves and 70 normal valves, were compared. Thresholds were developed on an initial cohort of patients with 55 regurgitant valves, and subsequently tested on a later cohort of patients with 52 regurgitant valves. Regurgitation fraction (RF) limits that optimized concordance of CMR and echo severity grades were similar for MR and AR and were: mild < or = 15%, moderate 16-25%, moderate-severe 26-48%, severe > 48%. CONCLUSIONS: The current study provides simple qualititative threshold grades for MR and AR severity that allows for standardized reporting of regurgitation severity by CMR and excellent correlation with clinical echocardiography.
Ethanol septal ablation has emerged as a less invasive alternative to surgical myomectomy for treatment of asymmetric hypertrophic obstructive cardiomyopathy (ASH). The procedure has very low mortality, but high-degree AV conduction block is a frequent complication. Prior studies have documented baseline left bundle branch block and high volume of ethanol injection (greater than 4 mL) as risk factors. Complete heart block is often preceded by postprocedure conduction abnormalities and generally develops within 48 hours after ethanol ablation. We present a unique case of a patient with symmetric hypertensive hypertrophic obstructive cardiomyopathy (SHOCM) who developed phase IV complete heart block >96 hours postprocedure without preceding conduction abnormalities or other classic risk factors.